Session: SAT 281-290-Comparative Effectiveness/Health Outcomes/Quality Improvement/Patient or Provider Education/Endocrine Emergencies
Poster Board SAT-282
The aim of this study was to assess whether the patients and the doctors were aware of the rules and recommendations in Portugal.
An anonymous questionnaire was applied to diabetic patients who were drivers attending our center during 8 weeks. A web-based questionnaire was e-mailed to the Endocrinology, Diabetes and Metabolism Portuguese Society and Diabetes Portuguese Society associates.
Ninety-three patients were surveyed (64 males and 29 females). Mean age was 59±14.4 years and the mean duration of diabetes was 13.35±10.05 years. Seventy-eight (83. 9 %) had type 2 diabetes and 15 (16.1%) had type 1 diabetes. Twenty-nine percent was treated with Insulin, 46% with oral medication and 25% with both. Only 20 patients had discussed this subject with their doctor and 69.9% thought there wasn´t any risk to drive being a diabetic. Twenty-nine percent never test blood glucose prior driving and for the majority (43.7%) it’s safe to drive until blood glucose is 60 mg/dl (3.3 mmol/L). Sixty patients always carry some source of sugar while driving. Eight patients have had at least one hypoglycemic episode during driving in the last 2 years, but only one reported a crash due to hypoglycemia. Eighty-eight doctors completed the questionnaire. Fourteen doctors didn’t associate diabetes with an increased risk of car accidents and 59.1% only discussed the driving and diabetes issue with less than 50% of their diabetic patients who were drivers. Only 54% advise their patients to test blood glycemia prior driving and for 46.6% it’s safe to drive with blood glucose lower than 90mg/dl (5 mmol/L). Sixteen (18.2%) didn’t know recurrent hypoglycemia was a contraindication to driving and eight that impaired awareness of hypoglycemia might also be a contraindication.
This study shows a lack of patients’ knowledge about safe driving and the rules they must follow. It seems this results from scant information and education given by health professionals. We would recommend a reinforcement of the medical staff information on this subject, in order to improve our patients’ education.
Nothing to Disclose: CSM, RF, FS, CV, AMS
*Please take note of The Endocrine Society's News Embargo Policy at http://www.endo-society.org/endo2013/media.cfm
See more of: Abstracts - Orals, Featured Poster Presentations, and Posters